AstraZeneca Projects Double-Digit Growth in Revenue and Earnings
2 Mins read
AstraZeneca, the renowned pharmaceutical company, anticipates a substantial increase in its revenue and core earnings per share in 2024. However, the company…
Icosavax Soars as AstraZeneca Announces Acquisition Deal
1 Mins read
Icosavax, a Seattle-based vaccine developer, experienced a significant boost in stock prices, surging by 47% in premarket trading on Tuesday. The reason…